MAPK3 and cancer: The RAS/MAPK pathway has been intensively studied [1–4], with constitutive activation of ERK1 and ERK2 found frequently in human cancer cells from a variety of tissues (e.g., lung, pancreas, colon, ovary, kidney, skin, and thyroid) [13].